Clinical trial
MitoQ for the Treatment of Metabolic Dysfunction in Asthma
NCT04026711 is registered in ClinicalTrials.gov with University of Vermont as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- MitoQ for the Treatment of Metabolic Dysfunction in Asthma
- Lead sponsor
- University of Vermont
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- January 1, 2020
- Completion date
- March 31, 2024
- Enrollment
- 47 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.